Delivery Order SPE2DB22D3501-SPE2DB24FWW79

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Norditropin FlexPro 10 mg/1.5 mL pharmaceutical products. The $3,642.14 firm-fixed-price delivery order contract has an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these specialty medications to support military treatment facilities and other federal healthcare programs. This award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,206.75 Firm Fixed Price delivery order is for the supply of Norditropin FlexPro 10 mg/1.5 1.5 ml, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 15 mg/1.5 medication. The contract, valued at $1,238.53, has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement. No set-aside designation was used for this award. AmerisourceBergen, through its Corporate Office...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,025.36 firm-fixed-price delivery order is for the supply of Norditropin FlexPro 15 mg/1.5 ml medication. The contract has a completion date of November 4, 2024 and was awarded on November 1, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award is for the delivery of the pharmaceutical product Norditropin FlexPro 10 mg/1.5 ml to the Defense Logistics Agency (DLA). The $2,338.08 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 26, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Norditropin FlexPro 15 mg/1.5 1.5 mL pharmaceutical products. The $1,417.92 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a firm-fixed price delivery order with a period of performance through October 17, 2024. Amerisourcebergen, as the prime contractor, will supply these specialized injectable medications to support federal healthcare programs,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order from the Defense Logistics Agency (DLA) valued at $1,002.60. The contract is for the supply of Norditropin FlexPro 15 mg/1.5 ml, a pharmaceutical product. The award has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts and Indefinite Delivery Contracts (IDCs) by various federal agencies, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,071.63 delivery order is for the supply of Norditropin FlexPro 30 mg/3 ml 3 ml, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,025.36 Firm Fixed Price delivery order is for the supply of Norditropin FlexPro 10 mg/1.5 ml, a medication used for various medical conditions. The contract has a completion date of July 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of Norditropin FlexPro 10 mg/1.5 ml medication. The $2,925.52 fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of July 5, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWW79
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $2,250.40, is a Firm Fixed Price Delivery Order for the supply of Norditropin FlexPro 10 mg/1.5 mL medication. The contract has a completion date of September 9, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded various federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal healthcare providers. This particular award is not designated as a set-aside contract.

Generated 12/6/24, 9:13 AM